INA03
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INA03, covering 2025-08-06 to 2025-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia [EARLY_Phase 1]